186 related articles for article (PubMed ID: 26027776)
1. Acquired hemophilia, rheumatoid arthritis, and TNFα antagonists: Comment on the article "Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis" by Banse et al., Joint Bone Spine 2015;82:200-2.
Brinster A; Bertrand MA; Guillot X; Sondag M; Wendling D
Joint Bone Spine; 2015 Oct; 82(5):384-5. PubMed ID: 26027776
[No Abstract] [Full Text] [Related]
2. Reply to the comment of Brinster et al. "Acquired hemophilia, rheumatoid arthritis, and TNFα antagonists".
Banse C; Vittecoq O; Lévesque H
Joint Bone Spine; 2015 Oct; 82(5):385-6. PubMed ID: 26162633
[No Abstract] [Full Text] [Related]
3. Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis.
Banse C; Benhamou Y; Lequerré T; Le Cam-Duchez V; Lévesque H; Vittecoq O
Joint Bone Spine; 2015 May; 82(3):200-2. PubMed ID: 25617259
[TBL] [Abstract][Full Text] [Related]
4. Fatal acquired hemophilia A in a patient with rheumatoid arthritis treated with adalimumab.
Arthanari S; Ahmad H; Nisar M
J Clin Rheumatol; 2012 Jan; 18(1):50-1. PubMed ID: 22157274
[No Abstract] [Full Text] [Related]
5. [Case Report; Long-term treatment with etanercept induced systemic sarcoidosis in a patient with rheumatoid arthritis].
Yokoe I; Haraoka H; Yonamine T; Sato R; Nishiwaki A; Takei M
Nihon Naika Gakkai Zasshi; 2015 Apr; 104(4):769-74. PubMed ID: 26536740
[No Abstract] [Full Text] [Related]
6. Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France.
Saint Marcoux B; De Bandt M;
Joint Bone Spine; 2006 Dec; 73(6):710-3. PubMed ID: 17127088
[TBL] [Abstract][Full Text] [Related]
7. Comparison of injection-site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study.
Girolomoni G; Feldman SR; Emery P; Ghil J; Keum JW; Cheong SY; Hong E
Br J Dermatol; 2018 Mar; 178(3):e215-e216. PubMed ID: 29023641
[No Abstract] [Full Text] [Related]
8. Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept.
Vieira MA; Saraiva MI; Silva LK; Fraga RC; Kakizaki P; Valente NY
Rev Assoc Med Bras (1992); 2016 Nov; 62(8):718-720. PubMed ID: 27992009
[TBL] [Abstract][Full Text] [Related]
9. A case of clinically amyopathic dermatomyositis that developed during anti-TNF-α therapy for rheumatoid arthritis.
Takata M; Yamasaki A; Yamada N; Hagino H; Funaki Y; Harada T; Okazaki R; Hasegawa Y; Fukushima T; Morita M; Sueda Y; Yamamoto A; Shimizu E
Allergol Int; 2018 Apr; 67(2):286-288. PubMed ID: 28964642
[No Abstract] [Full Text] [Related]
10. Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients Receiving Combination Therapy: Comment on the Article by Curtis et al.
Roongta R; Mondal S; Ghosh A
Arthritis Rheumatol; 2021 Sep; 73(9):1771. PubMed ID: 33750021
[No Abstract] [Full Text] [Related]
11. Effect of etanercept, infliximab and methotrexate in the treatment of arthritis.
Wang L; Liu Y; Su X; Liu S
Drug Res (Stuttg); 2015 Feb; 65(2):96-100. PubMed ID: 25050521
[TBL] [Abstract][Full Text] [Related]
12. Sarcoidosis induced by TNFα antagonists. Comments about the article by Vigne et al. (Joint Bone Spine 2013;80:104-7).
Toussirot É
Joint Bone Spine; 2014 Jan; 81(1):105-6. PubMed ID: 24289961
[No Abstract] [Full Text] [Related]
13. Counterintuitive Pulmonary Nodules in Rheumatoid Arthritis.
Zamora FD; Podgaetz E; Dincer HE
Arch Bronconeumol; 2016 Jun; 52(6):334-5. PubMed ID: 26818558
[No Abstract] [Full Text] [Related]
14. Sustained response to rituximab in a TNFi-induced ANCA-vasculitis developed in a patient with rheumatoid arthritis.
Florez H; Morlà R; Castellanos-Moreira R; Sanmartí R
Semin Arthritis Rheum; 2018 Feb; 47(4):e15-e16. PubMed ID: 29150206
[No Abstract] [Full Text] [Related]
15. Acquired hemophilia A and fulminant diabetes mellitus possibly caused by adalimumab in a patient with psoriatic arthritis.
Yamaguchi T; Itoh M; Umezawa Y; Asahina A; Hanabusa H; Nakagawa H
J Dermatol; 2017 Mar; 44(3):e3-e4. PubMed ID: 27206322
[No Abstract] [Full Text] [Related]
16. Highly suspected primary intraocular lymphoma in a patient with rheumatoid arthritis treated with etanercept: a case report.
Song WK; Cho AR; Yoon YH
BMC Ophthalmol; 2018 Jun; 18(1):156. PubMed ID: 29954352
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical psoriatic arthritis in a patient with rheumatoid arthritis treated by TNFα blocker.
Villani AP; Weiler L; Jullien D; Chapurlat R; Confavreux C
Joint Bone Spine; 2014 Oct; 81(5):455-6. PubMed ID: 24561024
[No Abstract] [Full Text] [Related]
18. Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review.
Downey C
Int J Rheum Dis; 2016 Jun; 19(6):536-50. PubMed ID: 26200188
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis Jirovecii Pneumonia in Japanese Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Pooled Analysis of 3 Agents.
Tanaka M; Sakai R; Koike R; Harigai M
J Rheumatol; 2015 Sep; 42(9):1726-8. PubMed ID: 26330129
[No Abstract] [Full Text] [Related]
20. Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
Pavelka K; Akkoç N; Al-Maini M; Zerbini CAF; Karateev DE; Nasonov EL; Rahman MU; Pedersen R; Dinh A; Shen Q; Vasilescu R; Kotak S; Mahgoub E; Vlahos B
Rheumatol Int; 2017 Sep; 37(9):1469-1479. PubMed ID: 28597306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
